VI . SUMMARY SCHEME 
Overview of Gene Therapy Program 
University Hospitals of Cleveland 
MetroHealth Medical Center 
Cleveland VAMC 
Tissue Procurement 
I 
I 
Gene Therapy 
I 
Patients Entered Sequentially into 
One of Three Dose Regimens 
I 
Assess Toxicity and Determine 
if Study is to Continue 
Proceed to Phase Two 
of the Study 
Determined by Primary 
Neurosurgeon 
[144] 
Recombinant DNA Research, Volume 18 
